March 20, 2014
Boston, MA
The USPTO has issued controversial new guidelines for the examination of claims to isolated natural products. Please join us for an interactive discussion on patenting strategies and validity assessments in view of these guidelines and in the wake of the Supreme Court’s Myriad and Mayo decisions. During this program we will provide updates on recent developments involving 35 U.S.C. § 101 before the U.S. Patent and Trademark Office (USPTO), Patent Trial and Appeal Board (PTAB), district and federal courts, and consider strategies for assessing validity and patenting claims directed to natural products, pharmaceutical compositions, products containing nucleic acids, and diagnostic methods.
Finnegan attorneys will discuss additional topics, including:
There is no charge to attend. Due to space limitations, please register early.
Leslie A. McDonell
Jeffrey M. Jacobstein
Alissa K. Lipton
Lulu Wang, Ph.D.
Thursday, March 20, 2014
2:45 - 3:00 p.m. - Registration
3:00 - 5:00 p.m. - Program
5:00 - 6:00 p.m. - Reception
Finnegan
Two Seaport Lane
Boston, MA 02210
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Webinar
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives
May 15, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.